Global Blood Screening Market – Industry Trends and Forecast to 2025

  • In Vitro Diagnostics
  • Publish Reports
  • Nov 2018
  • Global
  • 391 Pages
  • No of Tables: 56
  • No of Figures: 405

Global Blood Screening Market, By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)- Industry Trends and Forecast to 2025

Screening process can also be called as the first line of defense in health care field providing a safe blood supply and helping in minimizing the problems associated with transfusion-transmitted infection. Government associations of every country should establish blood donor programs to provide information and education about blood donations. Various techniques are available in the market to perform assays for detection of the problems related to health is Immunoassays (IAs) and Nucleic Acid Amplification Technology (NAT) assays. Immunoassay is categorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays and rapid/simple single-use assays (rapid tests).

Global blood screening market is expected to reach a healthy CAGR of 9.7% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Segmentation: Global Blood Screening Market 

Global blood screening market is categorized based on basis of products & services, technology, disease type and end user.

  • On the basis of product & services the market is segmented into reagents and kits, instruments and software & services. Reagents and kits are further sub segmented into NAT reagents & kits, ELISA reagents & kits others as well. NAT reagents is further sub segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions alsolabeling and detection reagents. ELISA reagents & kits is further sub segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) also sample diluents and wash solutions. Instruments segment is further segmented into instruments, product types and instruments, purchase type. In 2017, reagents & kits segment is expected to dominate the global blood screening market growing at the CAGR of 9.4% in the forecast period of 2018 to 2025.
  • In January 2017, F. Hoffmann-La Roche Ltd launched haematology testing solution. This solution is called the cobas m 511 integrated haematology analyser. This launch marked the entry for Roche Diagnostics in the haematology market.
  • On the basis of technology the market is segmented into nucleic acid test, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS) and others. Nucleic acid test is further sub segmented into transcription-mediated amplification (TMA) and real-time polymerase chain reaction (PCR). Enzyme-linked immunosorbent assay (ELISA) is further segmented into ELISA market, by platform, ELISA market, by generation. ELISA Market, By Platform is further sub segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA) and colorimetric immunoassay (CI). ELISA market, by generation is further segmented into first-generation ELISA, second-generation ELISA, third-generation ELISA and fourth-generation and above. In 2017, enzyme-linked immunosorbent assay (ELISA) segment is expected to dominate the global blood screening market growing at the CAGR of 9.8% in the forecast period of 2018 to 2025.
  • In September 2018, Thermo Fisher Scientific Inc. (U.S.), signed a definitive agreement with BD This business combines a strong technical service program with a variety of media and other products. This acquisition helped company to expand their business on global level with larger number of products.
  • On the basis of disease type, the market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and others. In 2017, oncology segment is expected to dominate the global blood screening marketgrowing at the highest CAGR of 10.3% in the forecast period of 2018 to 2025.
  • In June 2018, Thermo Fisher Scientific (U.S.) launched Oncomine TCR Beta-SR Assay. It is a new next-generation sequencing (NGS) solution in the field of immuno-oncology research. This helped company to expand their business by enhancing their product portfolio.
  • On the basis of end user the market is segmented into hospitals, clinics, diagnostic centers, blood bank and ambulatory surgical cenetrs. In 2017, diagnostic centers segment is expected to dominate the global blood screening market growing at the highest CAGR of 10.4%in the forecast period of 2018 to 2025.
  • In September 2016, Siemens Healthineers (Germany) acquired Conworx Technology GmbH (Germany) for point-of-care device interfaces and data management solutions. The company’s products and solutions designed helped in increasing efficiency and to reduce costs.

Competitive Analysis: Global Blood Screening Market 

Some of the prominent participants operating in this market are Enzo Biochem Inc., Meridian Bioscience, Inc. , BD , Bio-Rad Laboratories, Inc. , Thermo Fisher Scientific Inc., BioMérieux SA, Beckman Coulter, Inc., Abbott , F. Hoffmann-La Roche Ltd , Cepheid , GRIFOLS INTERNATIONAL, S.A. , Siemens AG , Ortho Clinical Diagnostics , Immucor, Inc., Hologic Inc., among others.

Product launch:

  • In March 2018, Bio-Rad Laboratories, Inc. launched IncRNA Workflow, a RT-qPCR workflow which is used to optimized for highly sensitive and specific quantification of long noncoding RNAs (lncRNAs) for gene expression analysis. The workflow provides a streamlined, cost-effective alternative to RNA-Seq for lncRNA discovery and validation.
  • In June 2018, Thermo Fisher Scientific launched Oncomine TCR Beta-SR Assay. It is a new next-generation sequencing (NGS) solution in the field of immuno-oncology research. This helped company to expand their business by enhancing their product portfolio.
  • In September 2018, Thermo Fisher Scientific Inc. , signed a definitive agreement with BD This business combines a strong technical services program with a variety of media and other products. This acquisition helped company to expand their business on global level with larger number of products.

Research Methodology: Global Blood Screening Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers


SKU-

TABLE OF CONTENTS GLOBAL BLOOD SCREENING MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF GLOBAL BLOOD SCREENING MARKET 1.4 CURRENCY AND PRICING 1.5 LIMITATION 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED 2.2 GEOGRAPHIC SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 RESEARCH METHODOLOGY 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7 DBMR MARKET POSITION GRID 2.8 THE CATEGORY VS TIME GRID 2.9 THE CATEGORY VS TIME GRID 2.10 DBMR MARKET CHALLENGE MATRIX 2.11 SECONDARY SOURCES 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS 3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES 3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS

3.2 RESTRAINTS

3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES 3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS 3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES

3.3 OPPORTUNITIES

3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING

3.4 CHALLENGES

3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT

4 EXECUTIVE SUMMARY 5 PREMIUM INSIGHTS 6 GLOBAL BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES

6.1 OVERVIEW 6.2 REAGENTS & KITS

6.2.1 ELISA REAGENTS & KITS

6.2.1.1 IMMUNOSORBENTS 6.2.1.2 CONJUGATES 6.2.1.3 SUBSTRATES 6.2.1.4 CONTROLS 6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS

6.2.2 NAT REAGENTS & KITS

6.2.2.1 PROBES AND PRIMERS 6.2.2.2 ENZYMES AND POLYMERASES 6.2.2.3 LABELING AND DETECTION REAGENTS 6.2.2.4 STANDARDS AND CONTROLS 6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS

6.3 INSTRUMENTS

6.3.1.1 INSTRUMENTS, PRODUCT TYPE

6.3.1.1.1 SEMI AUTOMATED 6.3.1.1.2 AUTOMATED

6.3.1.2 INSTRUMENTS, PURCHASE TYPE

6.3.1.2.1 OUTRIGHT PURCHASE 6.3.1.2.2 RENTAL

6.4 SOFTWARE & SERVICES

7 GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY

7.1 OVERVIEW 7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)

7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM

7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI) 7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA) 7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)

7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS

7.2.2.1 FIRST-GENERATION ELISA 7.2.2.2 SECOND-GENERATION ELISA 7.2.2.3 THIRD-GENERATION ELISA 7.2.2.4 FOURTH-GENERATION ELISA

7.3 RAPID TESTS 7.4 NEXT-GENERATION SEQUENCING (NGS) 7.5 NUCLEIC ACID TEST

7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR) 7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)

7.6 WESTERN BLOT ASSAY 7.7 OTHERS

8 GLOBAL BLOOD SCREENING MARKET, BY DISEASE TYPE

8.1 OVERVIEW 8.2 ONCOLOGY 8.3 DIABETES MELLITUS 8.4 COLD & FLU 8.5 CHOLESTEROL 8.6 INFECTIOUS DISEASES 8.7 RESPIRATORY DISEASES 8.8 HIV/AIDS 8.9 OTHERS

9 GLOBAL BLOOD SCREENING MARKET, BY END USER

9.1 OVERVIEW 9.2 DIAGNOSTIC CENTERS 9.3 BLOOD BANK 9.4 HOSPITALS 9.5 CLINICS 9.6 AMBULATORY SURGICAL CENTERS

10 GLOBAL BLOOD SCREENING MARKET, BY GEOGRAPHY

10.1 OVERVIEW 10.2 NORTH AMERICA

10.2.1 U.S. 10.2.2 CANADA 10.2.3 MEXICO

10.3 EUROPE

10.3.1 GERMANY 10.3.2 U.K. 10.3.3 FRANCE 10.3.4 ITALY 10.3.5 SPAIN 10.3.6 SWITZERLAND 10.3.7 NETHERLANDS 10.3.8 BELGIUM 10.3.9 RUSSIA 10.3.10 TURKEY 10.3.11 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA 10.4.2 JAPAN 10.4.3 SOUTH KOREA 10.4.4 INDIA 10.4.5 SINGAPORE 10.4.6 AUSTRALIA 10.4.7 THAILAND 10.4.8 MALAYSIA 10.4.9 INDONESIA 10.4.10 PHILIPPINES 10.4.11 REST OF ASIA-PACIFIC

10.5 SOUTH AMERICA

10.5.1 BRAZIL 10.5.2 REST OF SOUTH AMERICA

10.6 MIDDLE EAST & AFRICA

10.6.1 SOUTH AFRICA 10.6.2 REST OF MIDDLE EAST & AFRICA

11 GLOBAL BLOOD SCREENING MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: GLOBAL 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 11.3 COMPANY SHARE ANALYSIS: EUROPE 11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 COMPANY PROFILES

12.1 F. HOFFMANN-LA ROCHE LTD

12.1.1 COMPANY OVERVIEW 12.1.2 REVENUEANALYSIS 12.1.3 COMPANY SHARE ANALYSIS 12.1.4 PRODUCT PORTFOLIO 12.1.5 RECENT DEVELOPMENT

12.2 ABBOTT

12.2.1 COMPANY OVERVIEW 12.2.2 REVENUE ANALYSIS 12.2.3 COMPANY SHAREV ANALYSIS 12.2.4 PRODUCT PORTFOLIO 12.2.5 RECENT DEVELOPMENT

12.3 THERMO FISHER SCIENTIFIC INC.

12.3.1 COMPANY OVERVIEW 12.3.2 REVENUE ANALYSIS 12.3.3 COMPANY SHAREV ANALYSIS 12.3.4 PRODUCT PORTFOLIO 12.3.5 RECENT DEVELOPMENTS

12.4 SIEMENS AG

12.4.1 COMPANY OVERVIEW 12.4.2 REVENUE ANALYSIS 12.4.3 COMPANY SHAREV ANALYSIS 12.4.4 PRODUCT PORTFOLIO 12.4.5 RECENT DEVELOPMENTS

12.5 BIO-RAD LABORATORIES, INC.

12.5.1 1.3.1COMPANY OVERVIEW 12.5.2 REVENUE ANALYSIS 12.5.3 COMPANY SHAREV ANALYSIS 12.5.4 PRODUCT PORTFOLIO 12.5.5 RECENT DEVELOPMENTS

12.6 BD

12.6.1 COMPANY OVERVIEW 12.6.2 REVENUE ANALYSIS 12.6.3 PRODUCT PORTFOLIO 12.6.4 RECENT DEVELOPMENTS

12.7 BECKMAN COULTER, INC.

12.7.1 COMPANY OVERVIEW 12.7.2 GEOGRAPHICPRESENCE 12.7.3 PODUCT PORTFOLIO 12.7.4 RECENET DEVELOPEMENTS

12.8 BIOMÉRIEUX SA

12.8.1 COMPANY OVERVIEW 12.8.2 REVENUE ANALYSIS 12.8.3 PRODUCT PORTFOLIO 12.8.4 RECENT DEVELOPMENT

12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)

12.9.1 COMPANY OVERVIEW 12.9.2 GEOGRAPHIC PRESENCE 12.9.3 PRODUCT PORTFOLIO 12.9.4 RECENT DEVELOPMENT

12.10 ENZO BIOCHEM INC.

12.10.1 COMPANY OVERVIEW 12.10.2 REVENUE ANALYSIS 12.10.3 PRODUCT PORTFOLIO 12.10.4 RECENT DEVELOPMENTS

12.11 GRIFOLS INTERNATIONAL, S.A.

12.11.1 COMPANY OVERVIEW 12.11.2 REVENUE ANALYSIS 12.11.3 PRODUCT PORTFOLIO 12.11.4 RECENT DEVELOPMENTS

12.12 HOLOGIC INC.

12.12.1 COMPANY OVERVIEW 12.12.2 REVENUE ANALYSIS 12.12.3 PRODUCT PORTFOLIO 12.12.4 RECENT DEVELOPMENTS

12.13 IMMUCOR, INC.

12.13.1 COMPANY OVERVIEW 12.13.2 GEOGRAPHIC PRESENCE: 12.13.3 PRODUCT PORTFOLIO 12.13.4 RECENT DEVELOPMENTS

12.14 MERIDIAN BIOSCIENCE, INC.

12.14.1 COMPANY OVERVIEW 12.14.2 REVENUE ANALYSIS 12.14.3 PRODUCT PORTFOLIO 12.14.4 RECENT DEVELOPMENTS

12.15 ORTHO CLINICAL DIAGNOSTICS

12.15.1 COMPANY OVERVIEW 12.15.2 GEOGRAPHIC PRESENCE 12.15.3 PRODUCT PORTFOLIO 12.15.4 RECENT DEVELOPMENTS

13 RELATED REPORTS

LIST OF TABLES GLOBAL BLOOD SCREENING MARKET

TABLE 1 LIST OF PRICES FOR FEW DEVICES TABLE 2 GLOBAL BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION) TABLE 3 GLOBAL REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 4 GLOBAL REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 5 GLOBAL ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 6 GLOBAL NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 7 GLOBAL INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 8 GLOBAL INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 9 GLOBAL INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 10 GLOBAL SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 11 GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 12 GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 13 GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 14 GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION) TABLE 15 GLOBAL RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 16 GLOBAL NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 17 GLOBAL NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 18 GLOBAL NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 19 GLOBAL WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 20 GLOBAL OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 21 GLOBAL BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 22 GLOBAL ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 23 GLOBAL DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 24 GLOBAL COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 25 GLOBAL CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 26 GLOBAL INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 27 GLOBAL RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 28 GLOBAL HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 29 GLOBAL OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 30 GLOBAL BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 31 GLOBAL DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 32 GLOBAL BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 33 GLOBAL HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 34 GLOBAL CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 35 GLOBAL AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 36 GLOBAL BLOOD SCREENING MARKET, BY REGION, 2016 – 2025 (USD MILLION) TABLE 37 NORTH AMERICA BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION) TABLE 38 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 39 NORTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 40 NORTH AMERICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 41 NORTH AMERICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 42 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 43 NORTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 44 NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 45 NORTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 46 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 47 NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 48 NORTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 49 NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 50 U.S. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 51 U.S. REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 52 U.S. ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 53 U.S. NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 54 U.S. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 55 U.S. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 56 U.S. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 57 U.S. NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 58 U.S. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 59 U.S. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 60 U.S. BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 61 U.S. BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 62 CANADA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 63 CANADA REAGENTS & KITS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 64 CANADA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 65 CANADA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 66 CANADA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 67 CANADA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 68 CANADA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 69 CANADA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 70 CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 71 CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 72 CANADA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 73 CANADA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 74 MEXICO BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 75 MEXICO BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 76 MEXICO ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 77 MEXICO NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 78 MEXICO INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 79 MEXICO INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 80 MEXICO BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 81 MEXICO NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 82 MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 83 MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 84 MEXICO BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION) TABLE 85 MEXICO BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 86 EUROPE BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION) TABLE 87 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 88 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 89 EUROPE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 90 EUROPE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 91 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 92 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 93 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 94 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 95 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 96 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 97 EUROPE BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION) TABLE 98 EUROPE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 99 GERMANY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 100 GERMANY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 101 GERMANY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 102 GERMANY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 103 GERMANY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 104 GERMANY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 105 GERMANY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 106 GERMANY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 107 GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 108 GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 109 GERMANY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 110 GERMANY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 111 U.K. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 112 U.K. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 113 U.K. ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 114 U.K. NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 115 U.K. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 116 U.K. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 117 U.K. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 118 U.K. NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 119 U.K. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 120 U.K. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 121 U.K. BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 122 U.K. BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 123 FRANCE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 124 FRANCE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 125 FRANCE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 126 FRANCE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 127 FRANCE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 128 FRANCE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 129 FRANCE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 130 FRANCE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 131 FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 132 FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 133 FRANCE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 134 FRANCE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 135 ITALY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 136 ITALY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 137 ITALY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 138 ITALY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 139 ITALY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 140 ITALY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 141 ITALY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 142 ITALY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 143 ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 144 ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 145 ITALY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 146 ITALY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 147 SPAIN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 148 SPAIN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 149 SPAIN ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 150 SPAIN NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 151 SPAIN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 152 SPAIN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 153 SPAIN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 154 SPAIN NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 155 SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 156 SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 157 SPAIN BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 158 SPAIN BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 159 SWITZERLAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 160 SWITZERLAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 161 SWITZERLAND ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 162 SWITZERLAND NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 163 SWITZERLAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 164 SWITZERLAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 165 SWITZERLAND BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 166 SWITZERLAND NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 167 SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 168 SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 169 SWITZERLAND BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 170 SWITZERLAND BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 171 NETHERLANDS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 172 NETHERLANDS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 173 NETHERLANDS ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 174 NETHERLANDS NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 175 NETHERLANDS INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 176 NETHERLANDS INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 177 NETHERLANDS BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 178 NETHERLANDS NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 179 NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 180 NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 181 NETHERLANDS BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 182 NETHERLANDS BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 183 BELGIUM BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 184 BELGIUM BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 185 BELGIUM ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 186 BELGIUM NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 187 BELGIUM INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 188 BELGIUM INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 189 BELGIUM BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 190 BELGIUM NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 191 BELGIUM ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 192 BELGIUM ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 193 BELGIUM BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 194 BELGIUM BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 195 RUSSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 196 RUSSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 197 RUSSIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 198 RUSSIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 199 RUSSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 200 RUSSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 201 RUSSIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 202 RUSSIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 203 RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 204 RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 205 RUSSIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 206 RUSSIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 207 TURKEY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 208 TURKEY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 209 TURKEY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 210 TURKEY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 211 TURKEY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 212 TURKEY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 213 TURKEY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 214 TURKEY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 215 TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 216 TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 217 TURKEY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 218 TURKEY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 219 REST OF EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 220 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY COUTRY, 2016-2025 (USD MILLION) TABLE 221 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 222 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 223 ASIA-PACIFIC ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 224 ASIA-PACIFIC NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 225 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 226 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 227 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 228 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 229 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 230 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 231 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 232 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 233 CHINA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 234 CHINA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 235 CHINA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 236 CHINA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 237 CHINA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 238 CHINA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 239 CHINA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 240 CHINA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 241 CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 242 CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 243 CHINA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 244 CHINA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 245 JAPAN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 246 JAPAN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 247 JAPAN ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 248 JAPAN NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 249 JAPAN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 250 JAPAN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 251 JAPAN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 252 JAPAN NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 253 JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 254 JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 255 JAPAN BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 256 JAPAN BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 257 SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 258 SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 259 SOUTH KOREA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 260 SOUTH KOREA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 261 SOUTH KOREA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 262 SOUTH KOREA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 263 SOUTH KOREA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 264 SOUTH KOREA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 265 SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 266 SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 267 SOUTH KOREA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 268 SOUTH KOREA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 269 INDIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 270 INDIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 271 INDIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 272 INDIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 273 INDIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 274 INDIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 275 INDIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 276 INDIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 277 INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 278 INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 279 INDIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 280 INDIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 281 SINGAPORE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 282 SINGAPORE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 283 SINGAPORE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 284 SINGAPORE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 285 SINGAPORE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 286 SINGAPORE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 287 SINGAPORE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 288 SINGAPORE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 289 SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 290 SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 291 SINGAPORE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 292 SINGAPORE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 293 AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 294 AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 295 AUSTRALIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 296 AUSTRALIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 297 AUSTRALIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 298 AUSTRALIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 299 AUSTRALIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 300 AUSTRALIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 301 AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 302 AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 303 AUSTRALIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 304 AUSTRALIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 305 THAILAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 306 THAILAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 307 THAILAND ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 308 THAILAND NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 309 THAILAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 310 THAILAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 311 THAILAND BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 312 THAILAND NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 313 THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 314 THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 315 THAILAND BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 316 THAILAND BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 317 MALAYSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 318 MALAYSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 319 MALAYSIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 320 MALAYSIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 321 MALAYSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 322 MALAYSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 323 MALAYSIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 324 MALAYSIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 325 MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 326 MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 327 MALAYSIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 328 MALAYSIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 329 INDONESIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 330 INDONESIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 331 INDONESIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 332 INDONESIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 333 INDONESIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 334 INDONESIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 335 INDONESIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 336 INDONESIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 337 INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 338 INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 339 INDONESIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 340 INDONESIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 341 PHILIPPINES BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 342 PHILIPPINES BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 343 PHILIPPINES ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 344 PHILIPPINES NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 345 PHILIPPINES INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 346 PHILIPPINES INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 347 PHILIPPINES BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 348 PHILIPPINES NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 349 PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 350 PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 351 PHILIPPINES BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 352 PHILIPPINES BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 353 REST OF ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 354 SOUTH AMERICA BLOOD SCREENING MARKET, BY COUTRY, 2016-2025 (USD MILLION) TABLE 355 SOUTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 356 SOUTH AMERICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 357 SOUTH AMERICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 358 SOUTH AMERICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 359 SOUTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 360 SOUTH AMERICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 361 SOUTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 362 SOUTH AMERICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 363 SOUTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 364 SOUTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 365 SOUTH AMERICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 366 SOUTH AMERICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 367 BRAZIL BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 368 BRAZIL REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 369 BRAZIL ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 370 BRAZIL NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 371 BRAZIL INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 372 BRAZIL INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 373 BRAZIL BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 374 BRAZIL NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 375 BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 376 BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 377 BRAZIL BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 378 BRAZIL BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 379 REST OF SOUTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 380 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION) TABLE 381 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 382 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 383 MIDDLE EAST & AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 384 MIDDLE EAST & AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 385 MIDDLE EAST & AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 386 MIDDLE EAST & AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 387 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 388 MIDDLE EAST & AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 389 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 390 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 391 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION) TABLE 392 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 393 SOUTH AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 394 SOUTH AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 395 SOUTH AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 396 SOUTH AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 397 SOUTH AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 398 SOUTH AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 399 SOUTH AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 400 SOUTH AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 401 SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 402 SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 403 SOUTH AFRICA BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION) TABLE 404 SOUTH AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 405 REST OF MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)

LIST OF FIGURES GLOBAL BLOOD SCREENING MARKET

FIGURE 1 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION FIGURE 2 GLOBAL BLOOD SCREENING MARKET: DATA TRIANGULATION FIGURE 3 GLOBAL BLOOD SCREENING MARKET: DROC ANALYSIS FIGURE 4 GLOBAL BLOOD SCREENING MARKET:BOTTOM UP APPROACH FIGURE 5 GLOBAL BLOOD SCREENING MARKET:TOP DOWN APPROACH FIGURE 6 GLOBAL BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS FIGURE 7 GLOBAL BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID FIGURE 8 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID FIGURE 9 GLOBAL BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID FIGURE 10 GLOBAL BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL BLOOD SCREENING MARKET FIGURE 12 GLOBAL BLOOD SCREENING MARKET: SEGMENTATION FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE BLOOD SCREENING MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025 FIGURE 14 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025 FIGURE 15 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025 FIGURE 16 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFI TABLE REVENUE POCKETS FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 62 FIGURE 17 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017 FIGURE 18 GLOBAL BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017 FIGURE 19 GLOBAL BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017 FIGURE 20 GLOBAL BLOOD SCREENING MARKET: BY END USER, 2017 FIGURE 21 GLOBAL BLOOD SCREENING MARKET SNAPSHOT (2017) FIGURE 22 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2017) FIGURE 23 GLOBAL BLOOD SCREENING MARKET: BY GEOGRAPHY (2018 & 2025) FIGURE 24 GLOBAL BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025) FIGURE 25 GLOBAL BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES (2018 - 2025) FIGURE 26 NORTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017) FIGURE 27 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017) FIGURE 28 NORTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) FIGURE 29 NORTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025) FIGURE 30 NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) FIGURE 31 EUROPE BLOOD SCREENING MARKET SNAPSHOT (2017) FIGURE 32 EUROPE BLOOD SCREENING: BY COUNTRY (2017) FIGURE 33 EUROPE BLOOD SCREENING: BY COUNTRY (2018 & 2025) FIGURE 34 EUROPE BLOOD SCREENING MARKET BY COUNTRY (2017 & 2025) FIGURE 35 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) FIGURE 36 ASIA-PACIFIC BLOOD SCREENING MARKET SNAPSHOT (2017) FIGURE 37 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017) FIGURE 38 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) FIGURE 39 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025) FIGURE 40 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) FIGURE 41 SOUTH AMERICA BLOOD SCREENING MARKET SNAPSHOT (2017) FIGURE 42 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2017) FIGURE 43 SOUTH AMERICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) FIGURE 44 SOUTH AMERICA BLOOD SCREENING MARKET :BY COUNTRY (2017 & 2025) FIGURE 45 SOUTH AMERICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) FIGURE 46 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SNAPSHOT (2017) FIGURE 47 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2017) FIGURE 48 MIDDLE EAST & AFRICA BLOOD SCREENING: BY COUNTRY (2018 & 2025) FIGURE 49 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET : BY COUNTRY (2017 & 2025) FIGURE 50 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) FIGURE 51 GLOBAL BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%) FIGURE 52 NORTH AMERICA BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%) FIGURE 53 ASIA-PACIFIC BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%) FIGURE 54 ASIA-PACIFIC BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART